Pfizer’s Albert Bourla is among the CEOs who signed a letter against suspending mifepristone citing its impact on the FDA and the biotech industry. Read More
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.